首页> 外国专利> TRYPTOPHANE-2,3-DIOXYGENASE INHIBITOR COMPOUND (TDO) AND / OR INDOLEAMINE-2,3-DIOXYGENASE (IDO), PHARMACEUTICAL COMPOSITION, AND USE OF TRYPTOPHANE-2,3-DIOXYGENASE (TDO) INHIBITOR AND / OR INDOLEAMINE-2,3DIOXYGENASE (IDO) OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME FOR MANUFACTURE OF A MEDICINAL PRODUCT

TRYPTOPHANE-2,3-DIOXYGENASE INHIBITOR COMPOUND (TDO) AND / OR INDOLEAMINE-2,3-DIOXYGENASE (IDO), PHARMACEUTICAL COMPOSITION, AND USE OF TRYPTOPHANE-2,3-DIOXYGENASE (TDO) INHIBITOR AND / OR INDOLEAMINE-2,3DIOXYGENASE (IDO) OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME FOR MANUFACTURE OF A MEDICINAL PRODUCT

机译:TRYPTOPHANE-2,3-二氧合酶抑制剂(TDO)和/或吲哚胺2,3-二氧合酶(IDO),药物成分以及使用TRYPTOPHANE-2,3-DIOXYGENASE(TDO)抑制剂和/或吲哚胺2, 3DIOXYGENASE(IDO)或制造药品的同一药物盐

摘要

A tryptophan-2,3-dioxigenase (tdo) and / or indoleamine-2,3-dioxigenase (acid) inhibitor compound is provided for use in medicine, said compound comprises the following formula: wherein x1, x2, x3, x4 and x 5 may be the same or different and each is independently selected from c, neo; each atom having a dotted line may independently have a double bond or a single bond, provided that the valencies on each atom are maintained; each r1, r2, r3, r4, r5 and r7 may be present or absent and may be the same or different and is selected from h and a substituted or unsubstituted organic group provided that the number of such groups r present is such that the valences of x1, x2, x3, x4 and x5 are maintained; one or two groups r 6 may be present and are selected from h and a substituted or unsubstituted organic group, provided that the number of groups r 6 present is such that the valence of the carbon atom to which they are attached is maintained, and provided that at least one r6 is an organic group comprising an atom double bonded to an oxygen atom (preferably a carbonyl group or a sulfonyl group) at a position a, ß or ¿to the carbon atom to which r6 is attached and to which the double bonded atom is attached. to an oxygen atom is also attached to a heteroatom.
机译:提供了一种色氨酸-2,3-二氧合酶(tdo)和/或吲哚胺-2,3-二氧合酶(酸)抑制剂化合物用于医学,所述化合物包括下式:其中x1,x2,x3,x4和x 5可以相同或不同,并且各自独立地选自c,neo;每个具有虚线的原子可以独立地具有双键或单键,只要保持每个原子上的化合价即可;每个r1,r2,r3,r4,r5和r7可以存在或不存在,并且可以相同或不同,并且选自h和取代或未取代的有机基团,条件是存在的此类基团r的数量应使化合价x1,x2,x3,x4和x5保持不变;可以存在一个或两个基团r 6,并选自h和取代或未取代的有机基团,条件是存在的基团r 6的数目应能保持与它们相连的碳原子的化合价,并提供至少一个r 6是有机基团,该有机基团包括在与r 6相连的碳原子的a,ß或¿位上与氧原子(最好是羰基或磺酰基)双键的原子键原子相连。与氧原子相连的杂原子也与杂原子相连。

著录项

  • 公开/公告号BR112016022785B1

    专利类型

  • 公开/公告日2019-08-06

    原文格式PDF

  • 申请/专利权人 IOMET PHARMA LTD;

    申请/专利号BR20161122785

  • 申请日2015-03-19

  • 分类号A61K31/405;A61K31/404;A61K31/4045;A61K31/407;A61K31/4184;A61K31/4188;A61K31/423;A61K31/424;A61K31/4355;A61K31/437;A61P25;A61P31;A61P35;A61P37;A61P43;

  • 国家 BR

  • 入库时间 2022-08-21 12:03:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号